NICE: antibiotics should be restricted for COPD
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whetherÂ antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
The recommendation comes as NICE publishes draft antimicrobial prescribing guidance and a separate update to its 2010 clinical guideline on diagnosing and managing COPD in over 16s.Â The draft antimicrobial guidanceÂ recommends that antibiotics should be offered to people who have a severeÂ flare up of symptoms (severe acute exacerbations). However other factors should be taken into account, such as the number and severity of symptoms.
The guidance notes that acute exacerbations of COPD can be caused by factors including viral infections and
smoking. Only around half are caused by bacterial infections, so many exacerbations will not respond to antibiotics.
The evidence shows that there are limited benefits of using antibiotics for managing acute exacerbations of COPD and that itÂ is important other options are taken into account before antibiotics are prescribed.
COPD affects approximately 3 million people in the UK, 2 million of whom are undiagnosed.
Use this complete training programme to update your knowledge on the POM to P switch of Gina, and learn how to help women with postmenopausal vaginal atrophy